See more : Canadian Metals Inc. (CME.CN) Income Statement Analysis – Financial Results
Complete financial analysis of Sensus Healthcare, Inc. (SRTS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sensus Healthcare, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
- China Properties Group Limited (1838.HK) Income Statement Analysis – Financial Results
- Europa Oil & Gas (Holdings) plc (EOG.L) Income Statement Analysis – Financial Results
- Quantum-Si incorporated (QSIAW) Income Statement Analysis – Financial Results
- Suzhou Xingye Materials Technology Co.,Ltd. (603928.SS) Income Statement Analysis – Financial Results
- Arras Minerals Corp. (ARRKF) Income Statement Analysis – Financial Results
Sensus Healthcare, Inc. (SRTS)
About Sensus Healthcare, Inc.
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and in-office laser rental services. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 24.41M | 44.53M | 27.04M | 9.58M | 27.26M | 26.43M | 20.59M | 14.81M | 10.27M | 5.81M | 10.48M |
Cost of Revenue | 10.35M | 14.90M | 10.05M | 4.33M | 9.71M | 9.52M | 6.79M | 4.97M | 3.70M | 2.05M | 3.60M |
Gross Profit | 14.06M | 29.63M | 16.99M | 5.25M | 17.56M | 16.91M | 13.80M | 9.85M | 6.57M | 3.76M | 6.88M |
Gross Profit Ratio | 57.61% | 66.53% | 62.82% | 54.81% | 64.40% | 63.99% | 67.03% | 66.48% | 64.00% | 64.63% | 65.64% |
Research & Development | 3.68M | 3.46M | 3.44M | 4.16M | 6.42M | 6.26M | 5.49M | 1.82M | 1.47M | 1.58M | 1.33M |
General & Administrative | 5.16M | 5.01M | 4.59M | 3.99M | 4.00M | 4.12M | 3.72M | 3.47M | 1.59M | 1.65M | 1.45M |
Selling & Marketing | 5.61M | 6.33M | 4.84M | 5.34M | 9.10M | 8.53M | 8.31M | 4.92M | 3.74M | 4.21M | 3.97M |
SG&A | 10.76M | 11.34M | 9.43M | 9.33M | 13.11M | 12.66M | 12.03M | 8.38M | 5.33M | 5.86M | 5.42M |
Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 14.44M | 14.80M | 12.87M | 13.48M | 19.53M | 18.92M | 17.52M | 10.21M | 6.80M | 7.44M | 6.75M |
Cost & Expenses | 24.79M | 29.70M | 22.92M | 17.81M | 29.23M | 28.43M | 24.31M | 15.17M | 10.49M | 9.49M | 10.35M |
Interest Income | 992.00K | 382.00K | 2.00K | 52.56K | 268.29K | 139.28K | 75.81K | 38.54K | 1.78K | 820.00 | 1.25K |
Interest Expense | 0.00 | 2.00K | 1.00K | 14.23K | 0.00 | 156.69K | 68.88K | 21.87K | 17.79K | 20.03K | 20.47K |
Depreciation & Amortization | 461.00K | 315.00K | 613.00K | 721.87K | 545.72K | 658.26K | 387.92K | 337.58K | 315.60K | 272.65K | 265.56K |
EBITDA | 79.00K | 14.83M | 4.73M | -6.10M | -1.15M | -1.21M | -3.25M | 13.00K | 96.12K | -3.41M | 393.65K |
EBITDA Ratio | 0.32% | 34.16% | 15.24% | -100.03% | -6.24% | -7.06% | -17.69% | -2.19% | 0.94% | -58.63% | 3.76% |
Operating Income | -382.00K | 14.83M | 4.12M | -8.23M | -1.97M | -2.01M | -3.72M | -363.12K | -221.26K | -3.68M | 126.84K |
Operating Income Ratio | -1.57% | 33.30% | 15.24% | -85.98% | -7.22% | -7.59% | -18.06% | -2.45% | -2.15% | -63.34% | 1.21% |
Total Other Income/Expenses | 1.03M | 13.16M | -1.00K | 1.40M | 268.29K | -17.41K | 6.93K | 16.67K | -16.01K | -19.21K | -19.21K |
Income Before Tax | 652.00K | 27.99M | 4.12M | -6.84M | -1.70M | -2.02M | -3.71M | -346.45K | -237.27K | -3.70M | 107.63K |
Income Before Tax Ratio | 2.67% | 62.85% | 15.23% | -71.37% | -6.24% | -7.65% | -18.02% | -2.34% | -2.31% | -63.67% | 1.03% |
Income Tax Expense | 167.00K | 3.75M | -613.00K | -2.12M | -545.72K | 139.28K | -312.11K | -299.05K | 1.78K | 820.00 | 1.25K |
Net Income | 485.00K | 24.24M | 4.12M | -4.72M | -1.15M | -2.02M | -3.71M | -346.45K | -237.27K | -3.70M | 107.63K |
Net Income Ratio | 1.99% | 54.44% | 15.23% | -49.24% | -4.23% | -7.65% | -18.02% | -2.34% | -2.31% | -63.67% | 1.03% |
EPS | 0.03 | 1.47 | 0.25 | -0.29 | -0.07 | -0.14 | -0.28 | -0.03 | -0.02 | -0.37 | -0.04 |
EPS Diluted | 0.03 | 1.46 | 0.25 | -0.29 | -0.07 | -0.14 | -0.28 | -0.03 | -0.02 | -0.37 | -0.04 |
Weighted Avg Shares Out | 16.26M | 16.48M | 16.48M | 16.43M | 16.23M | 14.12M | 13.24M | 12.03M | 10.78M | 9.88M | 9.79M |
Weighted Avg Shares Out (Dil) | 16.27M | 16.62M | 16.50M | 16.43M | 16.23M | 14.12M | 13.24M | 12.03M | 10.78M | 9.89M | 9.89M |
Sensus Healthcare Reports Third Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Third Quarter
Sensus Healthcare, Inc. (SRTS) Outperforms Broader Market: What You Need to Know
Sensus Healthcare (SRTS) is on the Move, Here's Why the Trend Could be Sustainable
Sensus Healthcare, Inc. (SRTS) Ascends While Market Falls: Some Facts to Note
All You Need to Know About Sensus Healthcare (SRTS) Rating Upgrade to Strong Buy
Sensus Healthcare, Inc. (SRTS) Falls More Steeply Than Broader Market: What Investors Need to Know
Sensus Healthcare, Inc. (SRTS) is a Great Momentum Stock: Should You Buy?
Is Sensus Healthcare (SRTS) Stock Outpacing Its Medical Peers This Year?
Recent Price Trend in Sensus Healthcare (SRTS) is Your Friend, Here's Why
Wall Street Analysts Think Sensus Healthcare (SRTS) Could Surge 65.68%: Read This Before Placing a Bet
Source: https://incomestatements.info
Category: Stock Reports